FDA Inspection 1242156 — Equity Group Eufaula Division LLC
The FDA completed an inspection of Equity Group Eufaula Division LLC on April 30, 2024 in Banks, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 30, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Banks, AL (United States)